RhinoCyte's Series A - II Round

RhinoCyte raised a round of funding on July 08, 2014.

RhinoCyte is a biotechnology company that has developed a method of isolating adult stem cells located in the olfactory regions of the mucosal lining of the human nasal passageway, which can be used i…

Articles about RhinoCyte's Series A - II Round: